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Abstract 
Background: To determine the reliability of 
hematological indices and derived formulas in 
diagnosing beta thalassemia trait. 
Methods: In this observational cohort study, 
patients diagnosed as beta thalassaemia minor were 
included. All hematological indices were 
recorded.Haemoglobin electrophoresis was 
performed using capillarys 2 flex piercing system. 
An HbA2 value > 3.5% was considered as a cut-off 
point for beta-thalassemia trait. Fourteen 
haematological indices were then applied according 
to the formulae and cut off values. Percentage of 
positive cases accurately identified along with the 
mean, median and mode were calculated for each 
discrimination index. 
Results: The study cohort constituted of total 493 
patients, out of which 246 (49.9%) were male and 247 
(50.1%) were females. The mean age of all the 
patients was 20.34 +12.835, with range of 6-50 years. 
The mean haemoglobin level of all patients was 
10.82+1.64 and ranged between 4.60 and 16.30.  A red 
blood cell count more than  4.9 X 10 12/l and a MCH 
less that 25 pg were the most consistent findings.   
Srivastava index  was  more near to predicting beta 
thalassaemia minor .  
Conclusion: Red cell indices and discrimination 
factors have  a potential utility in screening for β 
thalassaemia trait , keeping in view their sensitivity 
and specificity  
Key Words : Discrimination indices,  Beta(β) 
thalassaemia trait,   
 
Introduction 
Beta (β) thalassaemia is considered as the world’s most 
wide spread genetic disease. In Pakistan the 
prevalence of its carrier rate varies from 5 to 7% in 
different areas. The disease’s severity , with high 
morbidity and mortality justifies the implementation 
of preventive strategies . Early screening of carriers 
and counseling is essential for prevention of  β – 
thalassaemia. 1,2 The confirmation of β – thalassaemia 
carriers is by detecting high HbA2 levels, on 
haemoglobin electrophoresis, or in rare cases by 
mutation analysis (e.g., cap site mutations). Red cell 
indices on automated blood counters and then 
different discriminating formulae, based on red cell 
indices, can significantly improve the selection of cases 
for further evaluation . 3-15 The purpose of using red 
blood cell indices to discriminate is to detect subjects 
who have a high probability of requiring appropriate 
follow up and to reduce unnecessary investigative 
costs. Various formulae have been proposed according 
to the index of red blood cells. All these formulae have 
been tested with different cut off values and then to 
evaluate their sensitivity and specificity.The ideal 
discriminating index will be the one which will have 
high sensitivity  ( to detect maximum number of  β – 
thalassaemia carriers ) and high specificity ( 
eliminating iron deficiency patients). 4,  8, 16-20  
Β- thalassaemia minor and iron deficiency anaemia are 
the most commonly encountered hypochromic 
microcytic anaemias. The differential diagnosis 
between iron deficiency anaemia and β – thalassaemia 
minor in an important concern for every physician to 
avoid unnecessary iron therapy and false diagnosis of 
beta thalassaemia minor, especially in pre- marriage 
counselling , towards prevention of  β – thalassaemia 
major baby birth and minimization of expenses . 
Prevention of β – thalassaemia major is one of the most 
important programs of health system especially in 
countries with high β – thalassaemia gene  prevalence . 
Screening of carriers, especially  extended family 
screening in a family with a case of beta thalassaemia 
major (index case) and counselling at risk couples are 
the most successful approaches in reduction of new 
cases of  β – thalassaemia major . 
Beta thalassaemia minor an iron deficiency anaemia   
have a similar pattern of hypochromic microcytic 
anaemia. Definitive methods for differential diagnosis 
between  β – thalassaemia minor and iron deficiency 
anaemia include haemoglobin electrophoresis and 
DNA mutation analysis. At mass level, if these 
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facilities are not available  then red blood cell indices 
and morphological examination of red cells 
morpohology , can give a road map how to proceed 
further. Red cell indices and then different 
discriminating factors can help to make a  safe guess.  
Peripheral blood film examination can also give a  
clue. Microcytic hypochromic red cells morphology 
with anisocytosis  proportionate to degree of anaemia 
and presence of pencil shape cells indicates iron 
deficiency , while uniformly microcytic hypochromic 
picture with target cells  and very minimal 
anisocytosis is indicative of β – thalassaemia minor . 
6,21  
 
Subjects and Methods 
This was on observational retrospective cohort study, 
conducted at  Punjab Thalassaemia Prevention 
Programme (PTPP) laboratories , at Holy Family 
hospital, Rawalpindi. All the patients diagnosed as 
beta thalassaemia minor form April to June 2015 were 
included. Ethical approval for the study was sought 
from institutional research board, Rawalpindi Medical 
College. Details of patients’age and sex were recorded. 
All hematological indices were recorded.The 
maximum time elapsed from blood sample collection 
till testing was 1 day.  
Table 1: discrimination indices for diagnosis of 
beta thalassemia trait. 
Discrimination 
index 
Formula applied Cut-off value for 
suspecting beta 
thalassemia trait 
Mentzer index 
(MI).18 
MCV/RBC < 13 
Shine & Lal index. 22  MCV MCV MCH
×0.01 
< 1530 
England  & Fraser 
Index. 23   
MCV- RBC-5×Hb-8.4 < 0 
Srivastava index. 16   MCH/RBC < 3.8 
Green & King Index. 
23  
MCV×MCV×RDW/
Hb×100 
< 65 
RBC distribution 
width index(RDWI) 
24  
MCV×RDW/RBC < 220 
Ricerca(R) index . 25 RDW/RBC < 3.3  
Keikhaei index. 26  Hb×RDW×100/RBC
×RBC×MCHC 
< 21 
Mean Density  of 
Hb/ litre of blood 
(MDHL). 27 
MCH/MCV×RBC >1.63 
Mean Cell Hb 
Density(MCHD) . 27 
MCH/MCV >0.3045 
Ehsani et al index. 19 MCV - 10× RBC <  15 
Sirdah et al index. 4  MCV-RBC-3×Hb <  27 
Hisham index . 13 MCH×RDW/RBC < 67 
Hameed index . 13  (MCH×Hct×RDW)/(
RBC×Hb) 
< 220 
None of the patients had received blood transfusion in 
the last 3 – 4 months. For each patient a 3 mL 
intravenous blood sample was collected in EDTA-
containing blood collection tubes. All samples were 
processed for haematological indices using a fully 
automated blood cell counter. Hemoglobin 
electrophoresis was performed on all the samples 
within 1 day using .Capillary’s 2 Flex Piercing system 
in the presence of controls and normal and abnormal 
haemoglobin curves noted. An HbA2 value > 3.5% 
was considered as a cut-off point for beta-thalassemia 
trait. Fourteen Haematological indices were then 
applied according to the formulae and cut off 
values,compared with that of Haemoglobin 
electrophoresis (Table 1). The proportion of Beta 
Thalassemia carriers identified correctly by each of 
these indices was computed. Percentage of positive 
cases accurately identified along with the mean, 
median and mode were calculated for each 
discrimination index. 
 
Results 
The study cohort constituted of total 493 patients, out 
of which 246 (49.9%) were male and 247 (50.1%) were 
females. The mean age of all the patients was 20.34 
+12.835, with range of 6-50 years. The mean 
hemoglobin level  was 10.52+1.71. 
Table 2: Red cell characteristics in β –
thalassaemia minor 
 Mean + SD Range 
Hb (g/dl) 10.53+ 1.71 8.1- 14.0 
RBC count (X 10 6/ul) 5.70 + 0.82 4.95-7.28 
MCV (fl) 58.21+ 3.86 48.30-73.80 
MCH (g/dl) 20.1 + 2.1 16.82- 25.2 
HbA2 (%) 4.90+ 0.61 3.6- 7.8 
 
Table 3: Summary of hematological indices in 
our study population. 
Index Cut off value Positive Negative Mean Median Mode
Standard 
deviation
Mentzer group <13 386, (78.3%) 106, (21.5%) 11.68 17.36 9.51 2.48
Shine And Lal group <1530 485, (98.0 %) 8, (1.6%) 819.86 789.83 467.17 394.75
England And Fraser < 0 356, (72.2%) 137, (27.8%) -4.6 -4.3 -7.3 -8.75
Srivastava < 4 493, (98.5% 0, (0%) 3.68 3.41 2.65 1.65
Green And King < 65 267, (54.2%) 226, (45.8%) 67.15 63.09 59.59 18.71
RDW index < 220 353, (71.6% ) 140, (28.4%) 205.29 192.45 167.72 55.52
Ricerca index < 3.3 323, (65.5%) 166, (33.7%) 3.24 3.05 2.84 0.86
Keikhaei index < 21 317, (64.3%) 174, (35.3%) 20.56 19.29 16.74 5.6
MDHL > 1.63 304, (61.7%) 181, (36.7%) 1.74 1.69 1.35 0.79
MCHD > 0.3045 240, (48.7%) 253, (51.3%) 0.31 0.3 0.33 0.13
Ehsani et al index < 15 382, (77.5%) 111, (22.5%) 7.71 7.8 -0.6 10.38
Sirdah et al index < 27 302, (61.3%) 191, (38.7%) 25.45 25.08 22.1 6.75
Hisham index < 67 348, (70.6%) 145, (29.4%) 64.58 58.74 47.35 29.17
Hameed Index < 220 353, (71.6%) 140, (28.4%) 208.32 192.52 168.73 87.67
 
Raised RBC count (> 4.9 X 106 / ul )and a decreased 
MCH  (<  25.2 g/dl) were the consistent findings 
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(Table 2) In our study population, Srivastava index 
was most successful in correctly predicting beta 
thalassemia trait in patients (correctly predicting in  
98% patients), while other indices such as MCHD and 
Green And King index did not have a very high 
predictive accuracy, (predicting correctly in 48.7% and 
54.2% people respectively) (Table 3). 
 
Discussion 
β – thalassaemia minor has a prevalence varying from 
5-7% in different areas of Pakistan. Early screening 
and counselling is  essential for     prevention of  β – 
thalassaemia major.1,2  In clinical practice , it can be 
assumed that red blood cell indices should be 
sufficient to raise suspicion of   β – thalassaemia minor 
and thereby leading to performance of further 
evaluation , in required cases. Despite this logical  
rationale , most  β – thalassaemia carriers are detected  
 randomly or during mass screening or when a new 
case emerged in a family . This backdrop situation as 
well as the burden of   β – thalassaemia     major 
patients for health services of a country have 
compelled many countries to develop screening 
programs  for β – thalassaemia prevention. Although 
the prevention programs  in many countries have 
succeeded  to lower the prevalence of giving birth to 
affective children, yet  they have financial  and 
operative constraints , especially in under or 
developing countries. 28 In Pakistan with this backdrop 
Punjab Thalassaemia Prevention Program (PTPP) was 
launched with an objective  to  provide free facility of 
carriers detection  in families (extended family 
screening)  where there is a case of   β – thalassaemia 
major (Index case) . This program also  offers free 
prenatal diagnosis services to couples where an 
unchecked pregnancy may lead to birth of β – 
thalassaemia major child .   Present study  comprises 
data of β – thalassaemia carriers diagnosed at PTPP 
laboratory at Holy Family Hospital , Rawalpindi  
In clinical practice it is required to differentiate iron 
deficiency anaemia and β – thalassaemia minor . In 
order to reduce the cost, time and complicated 
procedures for their discrimination, various  red blood 
cell indices and formulae have been used. The most  β 
– thalassaemia minor cases are asymptomatic and 
without  specialized tests may be missed or sometimes 
misdiagnosed as iron deficiency anaemia. 29 Lack  of 
access to specialized laboratory facilities across the 
country necessitates to screen out carriers at the first 
instance by first line tests. To a  greater extent this 
objective can be achieved by carefully analyzing red 
blood cell indices. 6 
The spectrum of β – thalassaemia mutations in each 
population can affect on various RBC indices , 
therefore it is suggested to determine cut off value for 
every formula in different population. 6 A high 
specificity and minimal false negative results are 
required to confirm the formulas’ reliability. 3  In a 
reliable formula , a negative predictive value higher 
than 99% is enough to recognize a formula reliable for 
daily   use . A program that intends to become safe for 
mass population screening should  miss as few false  
negative samples as possible. Sensitivity and 
specificity of these indices and formulae have been 
evaluated  in several studies. Varied results are likely 
to be due to different genetic mutations. It is required 
to establish cut off values for these discriminating 
factors in accordance with the population catered. 6,30-33  
Patients with microcytic hypochromic anaemia could 
be easily screened out  for β – thalassaemia minor and 
iron deficiency anaemia through these discrimination 
indices in the absence of other complicated diseases. 34 
Useful indicator of  β – thalassaemia minor identified 
was MCV and MCH less than 70 fl and 25 pg 
respectively, with normal or slightly decreased 
haemoglobin and raised red cell count greater than 5.0 
X 10 12  / l.  35  The goal  of a reliable screening test is to 
get as close as possible to zero false negative result  
with a minimal percentage of false positive results. 
Too many false negative can make a screening 
parameter unreliable . A big confounding variable is  β 
– thalassaemia carriers with a normal or near normal 
blood count indices. 3  In β – thalassaemia minor cases 
reduction in MCV and MCH did not correlate with the 
degree of anaemia , while red blood cells count is 
usually more than 5X 10 9 / l. 34,36  Mean MCV,  MCH 
and RBC  values  in present study are closely related 
with study of Yousafzai YM (2010). 1 A high MCV is 
known to be characteristic of specific mutations with 
milder disease . These cases with a MCV >75 fl are 
likely to give a false negative result on different 
discriminating variable. 30. MCH is found as a more 
significant distinguishing feature among 
thalassaemics. 39,40 The application of  Youden  index 
can further strengthen the specificity and sensitivity of 
a discriminating factor .8 An appropriate 
discriminating factor is the one which separates 
individuals with  β – thalassaemia minor from those 
without β – thalassaemia minor , regardless of their 
iron status.  37 Results of present study are 
substantiated by Porprasert S et al (2014), who showed 
that Srivastava and Sirdah formulae have 100% 
sensitivity and negative predictive value, the highest 
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efficiency (97.4%0 and the highest Youden’s index 
value (96.4%). 38  
 
Conclusion 
Careful analysis of red blood cells indices, along with 
applying discriminating factors , can help to make a 
substantial guess about β –thalassaemia minor . 
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